Iodine-123: Difference between revisions
CSV import |
CSV import |
||
| Line 31: | Line 31: | ||
{{radio-stub}} | {{radio-stub}} | ||
{{medicine-stub}} | {{medicine-stub}} | ||
<gallery> | |||
File:Sequence_of_123-iodide_total_body_human_scintiscans.jpg | |||
</gallery> | |||
Latest revision as of 22:01, 16 February 2025
Iodine-123 (also known as I-123) is a radioisotope of iodine used in nuclear medicine for diagnostic purposes. It is produced by the proton bombardment of xenon in a cyclotron, a type of particle accelerator.
Physical Characteristics[edit]
Iodine-123 has a half-life of approximately 13.2 hours. It decays by electron capture to stable tellurium-123, emitting gamma radiation with a primary energy of 159 keV, which is ideal for detection by a gamma camera.
Medical Uses[edit]
In nuclear medicine, Iodine-123 is used primarily for the evaluation of thyroid function. It is the preferred isotope for such studies, as it does not cause damage to the thyroid gland unlike Iodine-131, which is a beta particle emitter. Iodine-123 is also used in single photon emission computed tomography (SPECT) imaging of the brain to study blood flow and neurotransmitter activity.
Production and Availability[edit]
Iodine-123 is produced in a cyclotron by proton bombardment of xenon. The resulting xenon-123 undergoes beta decay to produce Iodine-123. The isotope is then purified and made available for medical use. Due to its short half-life, Iodine-123 must be used shortly after production.
Safety and Precautions[edit]
While Iodine-123 is less harmful than other iodine isotopes, precautions must still be taken when handling and administering it. Patients undergoing tests with Iodine-123 are exposed to radiation, and the risks must be weighed against the benefits of the diagnostic information obtained.
See Also[edit]
- Nuclear medicine
- Radioisotope
- Iodine-131
- Cyclotron
- Gamma camera
- Single photon emission computed tomography

